List of Categories
- Aerospace & Defense
- Agriculture
- Animal Nutrition & Wellness
- Automation
- Automotive
- Chemical & Materials
- Consumer Goods and Services
- Electronics
- Energy & Mining
- Financial Services & Investment Intelligence
- Food & Beverage
- Healthcare
- Heavy Industry
- Home & Property Improvement
- Information & Communications Technology
- Investment Opportunities
- Manufacturing
- NEO
- Others
- Packaging
- Retail
- Technology & Media
- Transportation & Logistics
Sorted by Name
Publishers
Countries
ORTHOPEDIC BRACES AND SUPPORTS MARKET: GLOBAL INDUSTRY TRENDS, SHARE, SIZE, GROWTH, OPPORTUNITY AND FORECAST 2019-2024
| Healthcare | Published by: IMARC GROUP | Market: |
| 122 pages | Published: 02-11-2019 |
- Healthcare
- IMARC GROUP
- 122 pages
- Published: 02-11-2019
The global orthopedic braces and supports market was worth US$ 3.8 Billion in 2018. Braces and supports are orthopedic equipment which are used externally for holding, aligning, correcting and supporting certain parts of the body while healing from an injury. They are manufactured using specialized materials with intelligent designs that offer intense targeted support to the knee, spine, foot, ankle, upper elbow, shoulder, hip and other body parts. Braces and supports also aid in safeguarding joints after surgeries and offer a sense of mobility to the patients suffering from musculoskeletal problems. Looking forward, the market value is projected to reach US$ 4.9 Billion by 2024, growing at a CAGR of 4.5% during 2019-2024.
Global Orthopedic Braces and Supports Market Drivers:
In comparison with invasive treatments, braces and supports are less painful, assist in quick recovery and reduce the incidences of post-surgical complications. On account of these factors, orthopedic braces and supports are preferred by patients worldwide.
Nowadays, consumers spend a significant part of their day in front of PCs, TVs and smart devices which result in the development of minor and major musculoskeletal deformities and dysfunctions. As a result, the demand for braces and supports is proliferating at a healthy rate.
The geriatric population is at a relatively higher risk of developing spondylitis, osteoarthritis, degenerative disc disease, and other mobility issues. Therefore, the growing elderly population is also contributing to the sales of braces and supports across the globe.
Manufacturers are developing pliable braces with a simplified user-interface, considering the requirements of consumers. They are also incorporating Velcro instead of laces to enable easy application and pulley systems in lumbar supports to allow easy customization.
Technological advancements have led to significant improvements in modeling and material technology and increased flexibility, contouring, and utilization of low-weight materials. Innovations have also led to the incorporation of advanced data sensors and synchronization systems.
Market Summary:
Based on the product, the market has been segmented into lower extremity braces and supports; spinal braces and supports; and upper extremity braces and supports.
Based on the type, the market has been segmented into soft and elastic braces and supports; hinged braces and supports; and hard and rigid braces and supports. Soft and elastic braces and supports currently have the highest share.
Based on the application, the market has been segmented into ligament injury, preventive care, post-operative rehabilitation, osteoarthritis and others. Ligament injury currently accounts for the highest share.
Based on the end-user, the market has been segmented into orthopedic clinics; hospitals and surgical centers; over-the-counter (OTC) platforms; and others. Orthopedic clinics currently account for the highest share.
Region-wise, the market has been segmented into North America, Asia Pacific, Europe, Middle East and Africa, and Latin America. Amongst these, North America is the biggest market, accounting for the majority of the global share.
The competitive landscape of the market has also been examined with some of the key players being Breg, Inc., Össur Hf, Bauerfeind AG, BSN Medical, DJO Finance LLC, 3M Company, Otto Bock Healthcare, Deroyal Industries, Inc., Medi GmbH & Co. KG, Thuasne Group, Alcare Co., Ltd, Zimmer Biomet Holdings, Inc., Trulife, Remington Products Company and Bird & Cronin.
Key Questions Answered in This Report:
- How has the global orthopedic braces and supports market performed so far and how will it perform in the coming years?
- What are the key regional markets in the global orthopedic braces and supports industry?
- What is the breakup of the global orthopedic braces and supports market on the basis of product?
- What is the breakup of the global orthopedic braces and supports market on the basis of type?
- What is the breakup of the global orthopedic braces and supports market on the basis of application?
- What is the breakup of the global orthopedic braces and supports market on the basis of end-user?
- What are the various stages in the value chain of the global orthopedic braces and supports market?
- What are the key driving factors and challenges in the global orthopedic braces and supports market?
- What is the structure of the global orthopedic braces and supports market and who are the key players?
- What is the degree of competition in the global orthopedic braces and supports market?
| 1 Preface 2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Orthopedic Braces and Supports Market 5.1 Market Overview 5.2 Market Performance 5.3 Market Breakup by Product 5.4 Market Breakup by Type 5.5 Market Breakup by Application 5.6 Market Breakup by End-User 5.7 Market Breakup by Region 5.8 Market Forecast 6 Market Breakup by Product 6.1 Lower Extremity Braces and Supports 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Spinal Braces and Supports 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 Upper Extremity Braces and Supports 6.3.1 Market Trends 6.3.2 Market Forecast 7 Market Breakup by Type 7.1 Soft and Elastic Braces and Supports 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Hinged Braces and Supports 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Hard and Rigid Braces and Supports 7.3.1 Market Trends 7.3.2 Market Forecast 8 Market Breakup by Application 8.1 Ligament Injury 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Preventive Care 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Post-Operative Rehabilitaion 8.3.1 Market Trends 8.3.2 Market Forecast 8.4 Osteoarthritis 8.4.1 Market Trends 8.4.2 Market Forecast 8.5 Others 8.5.1 Market Trends 8.5.2 Market Forecast 9 Market Breakup by End-User 9.1 Orthopedic Clinics 9.1.1 Market Trends 9.1.2 Market Forecast 9.2 Hospitals and Surgical Centers 9.2.1 Market Trends 9.2.2 Market Forecast 9.3 Over-the-Counter (OTC) Platforms 9.3.1 Market Trends 9.3.2 Market Forecast 9.4 Others 9.4.1 Market Trends 9.4.2 Market Forecast 10 Market Breakup by Region 10.1 North America 10.1.1 Market Trends 10.1.2 Market Forecast 10.2 Asia Pacific 10.2.1 Market Trends 10.2.2 Market Forecast 10.3 Europe 10.3.1 Market Trends 10.3.2 Market Forecast 10.4 Middle East and Africa 10.4.1 Market Trends 10.4.2 Market Forecast 10.5 Latin America 10.5.1 Market Trends 10.5.2 Market Forecast 11 Global Orthopedic Braces and Supports Industry: SWOT Analysis 11.1 Overview 11.2 Strengths 11.3 Weaknesses 11.4 Opportunities 11.5 Threats 12 Global Orthopedic Braces and Supports Industry: Value Chain Analysis 13 Global Orthopedic Braces and Supports Industry: Porters Five Forces Analysis 13.1 Overview 13.2 Bargaining Power of Buyers 13.3 Bargaining Power of Suppliers 13.4 Degree of Competition 13.5 Threat of New Entrants 13.6 Threat of Substitutes 14 Global Orthopedic Braces and Supports Industry: Price Analysis 15 Competitive Landscape 15.1 Market Structure 15.2 Key Players 15.3 Profiles of Key Players 15.3.1 Breg, Inc. 15.3.2 Össur Hf 15.3.3 Bauerfeind AG 15.3.4 BSN Medical 15.3.5 DJO Finance LLC 15.3.6 3M Company 15.3.7 Otto Bock Healthcare 15.3.8 Deroyal Industries, Inc. 15.3.9 Medi GmbH & Co. KG 15.3.10 Thuasne Group 15.3.11 Alcare Co., Ltd 15.3.12 Zimmer Biomet Holdings, Inc. 15.3.13 Trulife 15.3.14 Remington Products Company 15.3.15 Bird & Cronin |
Market Breakup by Product
- Lower Extremity Braces and Supports
- Spinal Braces and Supports
- Upper Extremity Braces and Supports
Market Breakup by Type
- Soft and Elastic Braces and Supports
- Hinged Braces and Supports
- Hard and Rigid Braces and Supports
Market Breakup by Application
- Ligament Injury
- Preventive Care
- Post-Operative Rehabilitaion
- Osteoarthritis
- Others
Market Breakup by End-User
- Orthopedic Clinics
- Hospitals and Surgical Centers
- Over-the-Counter (OTC) Platforms
- Others
Market Breakup by Region
- North America
- Asia Pacific
- Europe
- Middle East and Africa
- Latin America
CARDIAC BIOMARKERS MARKET: GLOBAL INDUSTRY TRENDS, SHARE, SIZE, GROWTH, OPPORTUNITY AND FORECAST 2019-2024
| Healthcare | Published by: IMARC GROUP | Market: |
| 130 pages | Published: 02-11-2019 |
- Healthcare
- IMARC GROUP
- 130 pages
- Published: 02-11-2019
The global cardiac biomarkers market was worth US$ 6.9 Billion in 2018. Cardiac markers, also known as cardiac biomarkers, are released into the bloodstream when the heart is stressed, or its muscles are damaged. These markers include different types of enzymes, hormones, and proteins, such as cardiac troponins, creatine kinase (CK), ischemia-modified albumin (IMA), and myoglobin. Measurement and testing of these markers can help in diagnosing heart conditions like cardiac ischemia and acute coronary syndrome (ACS). At present, the triage and diagnostic systems used for determining the risk of these conditions are based on electrocardiograms (ECGs) and clinical history. However, these systems are insufficient and can lead to misdiagnosis or delay in treatment. As cardiac marker testing offers higher accuracy and can identify the conditions in the early stages of presentation, they are gaining traction across the globe. These markers can also help in monitoring the prognosis of these condition with greater accuracy and providing the most effective treatment to the patients. Looking forward, the market value is projected to reach US$ 11.6 Billion by 2024, expanding at a CAGR of around 9% during 2019-2024.
Global Cardiac Biomarkers Market Drivers:
Over the past few years, there has been a rise in the number of patients suffering from ACS which has created a demand for cardiac marker testing at a global level. Other than this, rising awareness among patients and healthcare providers about the importance of early diagnosis of various CVDs is driving the demand for these markers. In addition, there are numerous private and public organizations which are investing in R&D activities to develop advanced technologies in the field of cardiac biomarkers. For instance, blood tests for high-sensitivity cardiac troponin I have been demonstrated to identify patients who are at a higher risk of a second heart attack. Moreover, high accuracy and rapid results offered by biomarker testing, coupled with the availability of affordable cardiac point-of-care testing, are some of the other factors which are contributing to the growth of the market.
Market Summary:
Based on the type, the market has been segmented into troponins (T and I), myocardial muscle creatine kinase (CK-MB), myoglobin, brain natriuretic peptide (BNPs) or NT-proBNP, ischemia modified albumin (IMA) and others.
Based on the location of testing, the market has been segmented into laboratory testing and point of care testing. Laboratory testing currently accounts for a larger share.
Based on the application, the market has been segmented into myocardial infarction, congestive heart failure, acute coronary syndrome, atherosclerosis and others. Myocardial infarction currently accounts for the highest share.
Region-wise, the market has been segmented into North America, Asia Pacific, Europe, Middle East and Africa, and Latin America. Amongst these, North America is the biggest market, accounting for the majority of the global share.
The competitive landscape of the market has also been examined with some of the key players being Abbott Laboratories, Alere Inc., Beckman Coulter, Becton, Dickinson And Co., Biomerieux, Bio-Rad Laboratories, Randox Laboratories, Roche Diagnostics Corporation, Siemens Healthcare and Thermo Fisher Scientific.
Key Questions Answered in This Report:
- How has the global cardiac biomarkers market performed so far and how will it perform in the coming years?
- What are the key regional markets in the global cardiac biomarkers industry?
- What is the breakup of the global cardiac biomarkers market on the basis of type?
- What is the breakup of the global cardiac biomarkers market on the basis of location of testing?
- What is the breakup of the global cardiac biomarkers market on the basis of application?
- What are the various stages in the value chain of the global cardiac biomarkers market?
- What are the key driving factors and challenges in the global cardiac biomarkers market?
- What is the structure of the global cardiac biomarkers market and who are the key players?
- What is the degree of competition in the global cardiac biomarkers market?
| 1. Preface 2. Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3. Executive Summary 4. Introduction 4.1 Overview 4.2 Key Industry Trends 5. Global Cardiac Biomarkers Market 5.1 Market Overview 5.2 Market Performance 5.3 Market Breakup by Type 5.4 Market Breakup by Location of Testing 5.5 Market Breakup by Application 5.6 Market Breakup by Region 5.7 Market Forecast 6. Market Breakup by Type 6.1 Troponins (T and I) 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Myocardial Muscle Creatine Kinase (CK-MB) 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 Myoglobin 6.3.1 Market Trends 6.3.2 Market Forecast 6.4 Brain Natriuretic Peptide (BNPs) or NT-proBNP 6.4.1 Market Trends 6.4.2 Market Forecast 6.5 Ischemia Modified Albumin (IMA) 6.5.1 Market Trends 6.5.2 Market Forecast 6.6 Others 6.6.1 Market Trends 6.6.2 Market Forecast 7. Market Breakup by Location of Testing 7.1 Laboratory Testing 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Point of Care Testing 7.2.1 Market Trends 7.2.2 Market Forecast 8. Market Breakup by Application 8.1 Myocardial Infarction 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Congestive Heart Failure 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Acute Coronary Syndrome 8.3.1 Market Trends 8.3.2 Market Forecast 8.4 Atherosclerosis 8.4.1 Market Trends 8.4.2 Market Forecast 8.5 Others 8.5.1 Market Trends 8.5.2 Market Forecast 9. Market Breakup by Region 9.1 North America 9.1.1 Market Trends 9.1.2 Market Forecast 9.2 Asia Pacific 9.2.1 Market Trends 9.2.2 Market Forecast 9.3 Europe 9.3.1 Market Trends 9.3.2 Market Forecast 9.4 Middle East and Africa 9.4.1 Market Trends 9.4.2 Market Forecast 9.5 Latin America 9.5.1 Market Trends 9.5.2 Market Forecast 10. Global Cardiac Biomarkers Industry: SWOT Analysis 10.1 Overview 10.2 Strengths 10.3 Weaknesses 10.4 Opportunities 10.5 Threats 11. Global Cardiac Biomarkers Industry: Value Chain Analysis 12. Global Cardiac Biomarkers Industry: Porters Five Forces Analysis 12.1 Overview 12.2 Bargaining Power of Buyers 12.3 Bargaining Power of Suppliers 12.4 Degree of Competition 12.5 Threat of New Entrants 12.6 Threat of Substitutes 13. Global Cardiac Biomarkers Industry: Price Analysis 14. Competitive Landscape 14.1 Market Structure 14.2 Key Players 14.3 Profiles of Key Players 14.3.1 Abbott Laboratories 14.3.2 Alere Inc. 14.3.3 Beckman Coulter 14.3.4 Becton, Dickinson And Co. 14.3.5 Biomerieux 14.3.6 Bio-Rad Laboratories 14.3.7 Randox Laboratories 14.3.8 Roche Diagnostics Corporation 14.3.9 Siemens Healthcare 14.3.10 Thermo Fisher Scientific |
Market Breakup by Type
- Troponins (T and I)
- Myocardial Muscle Creatine Kinase (CK-MB)
- Myoglobin
- Brain Natriuretic Peptide (BNPs) or NT-proBNP
- Ischemia Modified Albumin (IMA)
- Others
Market Breakup by Location of Testing
- Laboratory Testing
- Point of Care Testing
Market Breakup by Application
- Myocardial Infarction
- Congestive Heart Failure
- Acute Coronary Syndrome
- Atherosclerosis
- Others
Market Breakup by Region
- North America
- Asia Pacific
- Europe
- Middle East and Africa
- Latin America
CARDIOVASCULAR IMPLANTS MARKET: GLOBAL INDUSTRY TRENDS, SHARE, SIZE, GROWTH, OPPORTUNITY AND FORECAST 2019-2024
| Healthcare | Published by: IMARC GROUP | Market: |
| 135 pages | Published: 02-11-2019 |
- Healthcare
- IMARC GROUP
- 135 pages
- Published: 02-11-2019
The global cardiovascular implants market was worth US$ 19.8 Billion in 2018. Cardiovascular implants are used for patients suffering from cardiovascular conditions such as heart failure, myocardial infarction, and peripheral arterial and coronary artery diseases. Depending on their intended use, there are two broad categories of cardiovascular implants. The first type of implants remain inside the patients’ body throughout their lives to support or perform heart functions. On the other hand, temporary implants are utilized during surgeries or other medical procedures for taking over or managing heart functions. The growing prevalence of heart diseases, owing to changing dietary patterns, sedentary lifestyles and rising geriatric population, has resulted in high demand for cardiovascular implants across the globe.
Global Cardiovascular Implants Market Drivers:
Rising prevalence of cardiovascular disorders represents a key factor driving the demand of cardiovascular implants. Catalyzed by unhealthy diets and sedentary lifestyles, the prevalence of various cardiovascular disorders has increased across both developed and developing countries. Improving efficacy and safety of cardiovascular implants represents another major factor spurring the market growth. For instance, recent advancements in technology have opened opportunities for developing smart stent devices which can improve the diagnosis as well treatment of previously unmanageable conditions such as atherosclerosis and central line access failure. Apart from this, various government and non-profit organizations are also taking initiatives to improve the affordability of these devices. Other factors driving this market include ageing population, development in medical infrastructure, growing awareness levels and rising popularity of minimally invasive surgeries. Looking forward, the market value is projected to exceed US$ 27.1 Billion by 2024, expanding at a CAGR of around 5% during 2019-2024.
Market Summary:
Based on the product type, the market has been segmented into coronary stent, ICD, heart valve, implanted cardiac pacemaker, CRT device and peripheral stent.
Based on the material, the market has been segmented into metals and alloys, polymers and biological materials.
Based on the procedure type, the market has been segmented into angioplasty and open-heart surgery.
Based on the indication, the market has been segmented into arrhythmias, myocardial ischemia, acute myocardial infarction, congestive heart failure and others.
Region-wise, the market has been segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
The competitive landscape of the market has also been examined with some of the key players being Biotronik, Abbott Laboratories, AMG International, B-Braun, Johnson & Johnson, W.L. Gore & Associates, Medtronic, Boston Scientific, Sorin, Edwards Lifesciences, Fortimedix, Neovasc Inc., On-X Life Technologies, Proxy Biomedical, Reva Medical and Shree Pacetronix Ltd.
Key Questions Answered in This Report:
- How has the global cardiovascular implants market performed so far and how will it perform in the coming years?
- What is the breakup of the global cardiovascular implants market on the basis of region?
- What is the breakup of the global cardiovascular implants market on the basis of product?
- What is the breakup of the global cardiovascular implants market on the basis of material?
- What is the breakup of the global cardiovascular implants market on the basis of procedure type?
- What is the breakup of the global cardiovascular implants market on the basis of indication?
- What are the various stages in the value chain of the global cardiovascular implants market?
- What are the key driving factors and challenges in the global cardiovascular implants market?
- What is the structure of the global cardiovascular implants market and who are the key players?
- What is the degree of competition in the global cardiovascular implants market?
| 1. Preface 2. Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3. Executive Summary 4. Introduction 4.1 Overview 4.2 Properties 4.3 Key Industry Trends 5. Global Cardiovascular Implants Market 5.1 Market Overview 5.2 Market Performance 5.3 Market Breakup by Product 5.4 Market Breakup by Material 5.5 Market Breakup by Procedure Type 5.6 Market Breakup by Indication 5.7 Market Breakup by Region 5.8 Market Forecast 6. Market Breakup by Product 6.1 Coronary Stent 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 ICD 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 Heart Valve 6.3.1 Market Trends 6.3.2 Market Forecast 6.4 Implanted Cardiac Pacemaker 6.4.1 Market Trends 6.4.2 Market Forecast 6.5 CRT Device 6.5.1 Market Trends 6.5.2 Market Forecast 6.6 Peripheral Stent 6.6.1 Market Trends 6.6.2 Market Forecast 7. Market Breakup by Material 7.1 Metals and Alloys 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Polymers 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Biological Materials 7.3.1 Market Trends 7.3.2 Market Forecast 8. Market Breakup by Procedure Type 8.1 Angioplasty 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Open Heart Surgery 8.2.1 Market Trends 8.2.2 Market Forecast 9. Market Breakup by Indication 9.1 Arrhythmias 9.1.1 Market Trends 9.1.2 Market Forecast 9.2 Myocardial Ischemia 9.2.1 Market Trends 9.2.2 Market Forecast 9.3 Acute Myocardial Infarction 9.3.1 Market Trends 9.3.2 Market Forecast 9.4 Congestive Heart Failure 9.4.1 Market Trends 9.4.2 Market Forecast 9.5 Others 9.5.1 Market Trends 9.5.2 Market Forecast 10. Market Breakup by Region 10.1 North America 10.1.1 Market Trends 10.1.2 Market Forecast 10.2 Europe 10.2.1 Market Trends 10.2.2 Market Forecast 10.3 Asia Pacific 10.3.1 Market Trends 10.3.2 Market Forecast 10.4 Middle East and Africa 10.4.1 Market Trends 10.4.2 Market Forecast 10.5 Latin America 10.5.1 Market Trends 10.5.2 Market Forecast 11. Global Cardiovascular Implants Industry: SWOT Analysis 11.1 Overview 11.2 Strengths 11.3 Weaknesses 11.4 Opportunities 11.5 Threats 12 .Global Cardiovascular Implants Industry: Value Chain Analysis 13. Global Cardiovascular Implants Industry: Porters Five Forces Analysis 13.1 Overview 13.2 Bargaining Power of Buyers 13.3 Bargaining Power of Suppliers 13.4 Degree of Competition 13.5 Threat of New Entrants 13.6 Threat of Substitutes 14. Global Cardiovascular Implants Industry: Price Analysis 15. Competitive Landscape 15.1 Market Structure 15.2 Key Players 15.3 Profiles of Key Players 15.3.1 Biotronik 15.3.2 Abbott Laboratories 15.3.3 AMG International 15.3.4 B-Braun 15.3.5 Johnson & Johnson 15.3.6 W.L. Gore & Associates 15.3.7 Medtronic 15.3.8 Boston Scientific 15.3.9 Sorin 15.3.10 Edwards Lifesciences 15.3.11 Fortimedix 15.3.12 Neovasc Inc. 15.3.13 On-X Life Technologies 15.3.14 Proxy Biomedical 15.3.15 Reva Medical 15.3.16 Shree Pacetronix Ltd |
Market Breakup by Product
- Coronary Stent
- ICD
- Heart Valve
- Implanted Cardiac Pacemaker
- CRT Device
- Peripheral Stent
Market Breakup by Material
- Metals and Alloys
- Polymers
- Biological Materials
Market Breakup by Procedure Type
- Angioplasty
- Open Heart Surgery
Market Breakup by Indication
- Arrhythmias
- Myocardial Ischemia
- Acute Myocardial Infarction
- Congestive Heart Failure
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- Latin America
BIO-IMPLANTS MARKET: GLOBAL INDUSTRY TRENDS, SHARE, SIZE, GROWTH, OPPORTUNITY AND FORECAST 2019-2024
| Healthcare | Published by: IMARC GROUP | Market: |
| 130 pages | Published: 02-11-2019 |
- Healthcare
- IMARC GROUP
- 130 pages
- Published: 02-11-2019
The global bio-implants market was worth around US$ 86.4 Billion in 2018. Bio-implants are prostheses that are used for replacing, supporting or enhancing a biological structure. They are made up of different biosynthetic materials like collagen and tissue-engineered products like artificial skin. Bio-implants are majorly divided into three categories: biological implants that constitute bioartificial organs, cell therapy and tissue engineering; biologized implants that comprise of in-vivo cell lining, technical implants and biohybrid systems; and biofunctionalized implants that include surface-functionalized implants and drug-eluting stents. Bio-implants have been planted in various spheres of ENT and have resulted in some of the most successful surgical outcomes. They help to regularize physiological functions of patients which allows them to lead an efficient life.
Global Bio-Implants Market Drivers:
The growth of the bio-implants market is driven by a rise in the geriatric population around the world which is the largest end-user of these implants. Moreover, technological advancements and increasing awareness about the success of cosmetic implantations are providing a positive thrust to the market growth. Further, as dental implants are one of the biggest contributors to the growth of the bio-implants market, an increase in dental issues across the globe is aiding the market growth. Additionally, cardiac pacemakers and orthopedic artificial implants are in constant demand owing to the growing prevalence of cardiovascular and orthopedic conditions. Looking forward, the market is projected to reach a value of around US$ 136.3 Billion by 2024, expanding at a CAGR of around 8% during 2019-2024.
Market Summary:
Based on the type of bio-implants, the market has been segmented into cardiovascular implants, dental implants, spinal bio-implants, orthopaedic implants, ophthalmic implants and others.
Based on the type of material, the market has been segmented into metallic, ceramic, polymer and biological.
Based on the origin, the market has been segmented into allograft, autograft, xenograft and synthetic.
Based on the mode of administration, the market has been segmented into non-surgical and surgical.
Based on the end-users, the market has been segmented into ambulatory surgical centers, clinics, hospital and others.
Region-wise, the market has been segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
The competitive landscape of the market has also been examined with some of the key players being Abbott Laboratories, Boston Scientific Corporation, Stryker Corporation, St. Jude Medical Inc, Medtronic Inc., Smith and Nephew, Wright Medical Group, Zimmer Biomet, Dentsply Sirona, Invibio Limited, Straumann, Danaher Corporation, Cardinal Health, Johnson & Johnson, B. Braun Melsungen, LifeNet Health, Inc and Endo International plc.
Key Questions Answered in This Report:
- How has the global bio-implants market performed so far and how will it perform in the coming years?
- What is the breakup of the global bio-implants market on the basis of region?
- What is the breakup of the global bio-implants market on the basis of material?
- What is the breakup of the global bio-implants market on the basis of origin?
- What is the breakup of the global bio-implants market on the basis of mode of administration?
- What is the breakup of the global bio-implants market on the basis of end-users?
- What are the various stages in the value chain of the global bio-implants market?
- What are the key driving factors and challenges in the global bio-implants market?
- What is the structure of the global bio-implants market and who are the key players?
- What is the degree of competition in the global bio-implants market?
| 1. Preface 2. Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3. Executive Summary 4. Introduction 4.1 Overview 4.2 Properties 4.3 Key Industry Trends 5. Global Bio-Implants Market 5.1 Market Overview 5.2 Market Performance 5.3 Market Breakup by Type of Bio-Implants 5.4 Market Breakup by Material 5.5 Market Breakup by Origin 5.6 Market Breakup by Mode of Administration 5.7 Market Breakup by End-Users 5.8 Market Breakup by Region 5.9 Market Forecast 6. Market Breakup by Type of Bio-Implants 6.1 Cardiovascular Implants 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Dental Implants 7.1.1 Market Trends 7.1.2 Market Forecast 6.3 Spinal Bio-implants 7.1.1 Market Trends 7.1.2 Market Forecast 6.4 Orthopaedic Implants 7.1.1 Market Trends 7.1.2 Market Forecast 6.5 Ophthalmic Implants 7.1.1 Market Trends 7.1.2 Market Forecast 6.6 Others 7.1.1 Market Trends 7.1.2 Market Forecast 7. Market Breakup by Material 7.1 Metallic 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Ceramic 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Polymer 7.3.1 Market Trends 7.3.2 Market Forecast 7.4 Biological 7.4.1 Market Trends 7.4.2 Market Forecast 8. Market Breakup by Origin 8.1 Allograft 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Autograft 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Xenograft 8.3.1 Market Trends 8.3.2 Market Forecast 8.4 Synthetic 8.4.1 Market Trends 8.4.2 Market Forecast 9. Market Breakup by Mode of Administration 9.1 Non Surgical 9.1.1 Market Trends 9.1.2 Market Forecast 9.2 Surgical 9.2.1 Market Trends 9.2.2 Market Forecast 10. Market Breakup by End-Users 10.1 Ambulatory Surgical Centers 10.1.1 Market Trends 10.1.2 Market Forecast 10.2 Clinics 10.2.1 Market Trends 10.2.2 Market Forecast 10.3 Hospital 10.3.1 Market Trends 10.3.2 Market Forecast 10.4 Others 10.4.1 Market Trends 10.4.2 Market Forecast 11. Market Breakup by Region 11.1 North America 11.1.1 Market Trends 11.1.2 Market Forecast 11.2 Europe 11.2.1 Market Trends 11.2.2 Market Forecast 11.3 Asia Pacific 11.3.1 Market Trends 11.3.2 Market Forecast 11.4 Middle East and Africa 11.4.1 Market Trends 11.4.2 Market Forecast 11.5 Latin America 11.5.1 Market Trends 11.5.2 Market Forecast 12. Global Bio-Implants Industry: SWOT Analysis 12.1 Overview 12.2 Strengths 12.3 Weaknesses 12.4 Opportunities 12.5 Threats 13. Global Bio-Implants Industry: Value Chain Analysis 13.1 Overview 13.2 Research and Development 13.3 Raw Material Procurement 13.4 Manufacturing 13.5 Marketing 13.6 Distribution 13.7 End-Use 14. Global Bio-Implants Industry: Porters Five Forces Analysis 14.1 Overview 14.2 Bargaining Power of Buyers 14.3 Bargaining Power of Suppliers 14.4 Degree of Competition 14.5 Threat of New Entrants 14.6 Threat of Substitutes 15. Global Bio-Implants Industry: Price Analysis 15.1 Price Indicators 15.2 Price Structure 15.3 Margin Analysis 16. Bio-Implants Manufacturing Process 16.1 Product Overview 16.2 Raw Material Requirements 16.3 Manufacturing Process 16.4 Key Success and Risk Factors 17. Competitive Landscape 17.1 Market Structure 17.2 Key Players 17.3 Profiles of Key Players 17.3.1 Abbott Laboratories 17.3.2 Boston Scientific Corporation 17.3.3 Stryker Corporation 17.3.4 St. Jude Medical Inc 17.3.5 Medtronic Inc. 17.3.6 Smith and Nephew 17.3.7 Wright Medical Group 17.3.8 Zimmer Biomet 17.3.9 Dentsply Sirona 17.3.10 Invibio Limited 17.3.11 Straumann 17.3.12 Danaher Corporation 17.3.13 Cardinal Health 17.3.14 Johnson & Johnson 17.3.15 B. Braun Melsungen 17.3.16 LifeNet Health, Inc 17.3.17 Endo International plc |
Market Breakup by Type of Bio-Implants
- Cardiovascular Implants
- Dental Implants
- Spinal Bio-implants
- Orthopaedic Implants
- Ophthalmic Implants
- Others
Market Breakup by Material
- Metallic
- Ceramic
- Polymer
- Biological
Market Breakup by Origin
- Allograft
- Autograft
- Xenograft
- Synthetic
Market Breakup by Mode of Administration
- Non Surgical
- Surgical
Market Breakup by End-Users
- Ambulatory Surgical Centers
- Clinics
- Hospital
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- Latin America
ANIMAL HEALTH MARKET: GLOBAL INDUSTRY TRENDS, SHARE, SIZE, GROWTH, OPPORTUNITY AND FORECAST 2019-2024
| Healthcare | Published by: IMARC GROUP | Market: |
| 123 pages | Published: 02-11-2019 |
- Healthcare
- IMARC GROUP
- 123 pages
- Published: 02-11-2019
The global animal health market was worth more than US$ 44 Billion in 2018. Animals regularly require adequate care from their owners in order to have a good health. As the production of healthy livestock ensures safe food supply and retains the stability of consumer prices, regular monitoring of animal health and averting animal disease outbreaks have become indispensable for every country. As effective control and prevention is necessary for limiting the spread of zoonotic diseases among animals and human beings, the animal health market is gradually gaining traction across the globe. Moreover, pet and livestock owners nowadays are willing to spend on animal healthcare products and services owing to their inflating disposable incomes, growing awareness through print and electronic media, and the emerging trend of pet humanization.
Global Animal Health Market Drivers:
Currently, the animal health industry is flourishing on account of rapid technological advancements and increasing research and development activities in the veterinary pharmaceutical industry. With the help of advanced technological systems, data produced in veterinary clinics can be now uploaded on the internet and shared with other researchers and clinicians. This technology also aids in facilitating real-time analysis of fluctuations in the prevalence of diseases. In order to optimize the veterinary healthcare sector, governments in several developed countries are also undertaking initiatives and implementing animal vaccination programs. On account of these factors, the market value is projected to exceed US$ 58 Billion by 2024, exhibiting a CAGR of around 5% during 2019-2024.
Breakup by Animal Type:
On the basis of animal types, the market has been bifurcated into commercial and companion animals. At present, commercial animals account for the majority of the market share.
Breakup by Product Type:
Based on the product type, the animal health market has been divided into pharmaceuticals, biologicals, medicinal feed additives and diagnostics. Pharmaceuticals currently represent the largest product type.
Regional Insights:
On a geographical front, North America enjoys the leading position in the global animal health market. Other regions include Europe, Asia Pacific, Latin America, and Middle East and Africa.
Competitive Landscape:
The market is highly fragmented in nature with the presence of several small as well as large players who compete in terms of prices and quality. Some of the major players operating in the market include:
Bayer
Elanco
Merck
Merial
Zoetis Inc.
Biogenesis Bago
Boehringer Ingelheim
Ceva Sante Animale
Heska
Neogen
Novartis
Thermo Fisher Scientific
Vetoquinol
Virbac
Key Questions Answered in This Report:
- How has the global animal health market performed so far and how will it perform in the coming years?
- What are the key regions in the global animal health market?
- Which are the popular animal types in the global animal health market?
- What are the key product types in the global animal health market?
- What are the various stages in the value chain of the global animal health market?
- What are the key driving factors and challenges in the global animal health market?
- What is the structure of the global animal health market and who are the key players?
- What is the degree of competition in the global animal health market?
| 1. Preface 2. Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3. Executive Summary 4. Introduction 4.1 Overview 4.2 Key Industry Trends 5. Global Animal Health Market 5.1 Market Overview 5.2 Market Performance 5.3 Market Breakup by Animal Type 5.4 Market Breakup by Product 5.5 Market Breakup by Region 5.6 Market Forecast 6. Market Breakup by Animal Type 6.1 Commercial 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Companion 6.2.1 Market Trends 6.2.3 Market Forecast 7. Market Breakup by Product 7.1 Pharmaceuticals 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Biologicals 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Medicinal Feed Additives 7.3.1 Market Trends 7.3.2 Market Forecast 7.4 Diagnostics 7.4.1 Market Trends 7.4.2 Market Forecast 8. Market Breakup by Region 8.1 North America 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Europe 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Asia Pacific 8.3.1 Market Trends 8.3.2 Market Forecast 8.4 Middle East and Africa 8.4.1 Market Trends 8.4.2 Market Forecast 8.5 Latin America 8.5.1 Market Trends 8.5.2 Market Forecast 9. Global Animal Health Industry: SWOT Analysis 9.1 Overview 9.2 Strengths 9.3 Weaknesses 9.4 Opportunities 9.5 Threats 10. Global Animal Health Industry: Value Chain Analysis 11. Global Animal Health Industry: Porters Five Forces Analysis 11.1 Overview 11.2 Bargaining Power of Buyers 11.3 Bargaining Power of Suppliers 11.4 Degree of Competition 11.5 Threat of New Entrants 11.6 Threat of Substitutes 12. Global Animal Health Industry: Price Analysis 12.1 Price Indicators 12.2 Price Structure 12.3 Margin Analysis 13. Competitive Landscape 13.1 Market Structure 13.2 Key Players 13.3 Profiles of Key Players 13.3.1 Bayer 13.3.2 Elanco 13.3.3 Merck 13.3.4 Merial 13.3.5 Zoetis Inc. 13.3.6 Biogenesis Bago 13.3.7 Boehringer Ingelheim 13.3.8 Ceva Sante Animale 13.3.9 Heska 13.3.10 Neogen 13.3.11 Novartis 13.3.12 Thermo Fisher Scientific 13.3.13 Vetoquinol 13.3.14 Virbac |
Market Breakup by Animal Type
- Commercial
- Companion
Market Breakup by Product
- Pharmaceuticals
- Biologicals
- Medicinal Feed Additives
- Diagnostics
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- Latin America
TRAVEL VACCINES MARKET: GLOBAL INDUSTRY TRENDS, SHARE, SIZE, GROWTH, OPPORTUNITY AND FORECAST 2019-2024
| Healthcare | Published by: IMARC GROUP | Market: |
| 120 pages | Published: 02-11-2019 |
- Healthcare
- IMARC GROUP
- 120 pages
- Published: 02-11-2019
The global travel vaccines market was worth US$ 4.9 Billion in 2018. Travel vaccines, also known as travel immunizations, are vaccines travelers can get before they visit certain regions across the globe which help protect them from serious diseases. Travel vaccines work by exposing the body to a microorganism or parts of the microorganism of the disease it will protect against. The body responds to the vaccination by making antibodies that will protect it against a situation where there is an exposure to the disease in the future.
The number of international tourist arrivals worldwide increased from around 1.0 Billion in 2012 to nearly 1.4 Billion in 2018. A significant number of these travelers traveled from developed countries to regions with endemic diseases. As more people travel to countries with endemic disease, demand for vaccinations will continue to increase. Morever, regulatory authorities across the globe have also mandated that travelers should be vaccinated before travelling to disease-prone regions. As a result, travel vaccines have now become an important requirement in an international travelers list. For instance, The Ministry of Health in the kingdom of Saudi Arabia requires that all travelers arriving for Hajj and Umrah from countries or areas at risk of diseases such as yellow fever, Meningococcal meningitis, Poliomyelitis, etc. must present a valid vaccination certificate. Other factors driving the demand of travel vaccines include increasing awareness levels, technological advancements, increasing incidence of life-threatening infectious diseases, etc. Looking forward, we expect the global travel vaccine market to reach a value of US$ 8.1 billion by 2024, exhibiting a CAGR of around 9% during 2019-2024.
Market Summary:
Based on the composition, the market has been segmented into mono vaccines and combination vaccines.
Based on the disease, the market has been segmented into hepatitis A, hepatitis B, Japanese encephalitis vaccines, meningococcal, rabies, typhoid, yellow fever and others.
Region-wise, the market has been segmented into North America, Europe, Asia Pacific, Middle East and Africa and Latin America. Amongst these, North America is the biggest market, accounting for the majority of the global sales.
The competitive landscape of the market has also been examined with some of the key players being GlaxoSmithKline, Sanofi, Merck, Novartis, Pfizer, ALK-Abelló, Bavarian Nordic, Crucell N.V., CSL Limited, MedImmune, LLC, Altimmune, Abbott Laboratories and F. Hoffman-La Roche Ltd.
Key Questions Answered in This Report:
- How has the global travel vaccines market performed so far and how will it perform in the coming years?
- What are the key regional markets in the global travel vaccines industry?
- What is the breakup of the global travel vaccines market on the basis of composition?
- What is the breakup of the global travel vaccines market on the basis of disease?
- What are the various stages in the value chain of the global travel vaccines market?
- What are the key driving factors and challenges in the global travel vaccines market?
- What is the structure of the global travel vaccines market and who are the key players?
- What is the degree of competition in the global travel vaccines market?
| 1. Preface 2. Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3. Executive Summary 4. Introduction 4.1 Overview 4.2 Key Industry Trends 5. Global Travel Vaccines Market 5.1 Market Overview 5.2 Market Performance 5.3 Market Breakup by Composition 5.4 Market Breakup by Disease 5.5 Market Breakup by Region 5.6 Market Forecast 6. Market Breakup by Composition 6.1 Mono Vaccines 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Combination Vaccines 6.2.1 Market Trends 6.2.2 Market Forecast 7. Market Breakup by Disease 7.1 Hepatitis A 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Hepatitis B 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Japanese Encephalitis Vaccines 7.3.1 Market Trends 7.3.2 Market Forecast 7.4 Meningococcal 7.4.1 Market Trends 7.4.2 Market Forecast 7.5 Rabies 7.5.1 Market Trends 7.5.2 Market Forecast 7.6 Typhoid 7.6.1 Market Trends 7.6.2 Market Forecast 7.7 Yellow Fever 7.7.1 Market Trends 7.7.2 Market Forecast 7.8 Others 7.8.1 Market Trends 7.8.2 Market Forecast 8. Market Breakup by Region 8.1 North America 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Europe 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Asia Pacific 8.3.1 Market Trends 8.3.2 Market Forecast 8.4 Middle East and Africa 8.4.1 Market Trends 8.4.2 Market Forecast 8.5 Latin America 8.5.1 Market Trends 8.5.2 Market Forecast 9. Global Travel Vaccines Industry: SWOT Analysis 9.1 Overview 9.2 Strengths 9.3 Weaknesses 9.4 Opportunities 9.5 Threats 10. Global Travel Vaccines Industry: Value Chain Analysis 10.1 Exploratory Stage 10.2 Preclinical and Clinical Development 10.3 Regulatory Approval 10.4 Manufacturing 10.5 Marketing and Distribution 11. Global Travel Vaccines Industry: Porters Five Forces Analysis 11.1 Overview 11.2 Bargaining Power of Buyers 11.3 Bargaining Power of Suppliers 11.4 Degree of Competition 11.5 Threat of New Entrants 11.6 Threat of Substitutes 12. Global Travel Vaccines Industry: Price Analysis 13. Travel Vaccines Manufacturing Process 13.1 Product Overview 13.2 Raw Material Requirements 13.3 Manufacturing Process 13.4 Key Success and Risk Factors 14. Competitive Landscape 14.1 Market Structure 14.2 Key Players 14.3 Profiles of Key Players 14.3.1 GlaxoSmithKline 14.3.2 Sanofi Pasteur 14.3.3 Merck 14.3.4 Novartis 14.3.5 Pfizer 14.3.6 ALK-Abelló 14.3.7 Bavarian Nordic 14.3.8 Crucell N.V. 14.3.9 CSL Limited 14.3.10 MedImmune, LLC 14.3.11 Altimmune 14.3.12 Abbott Laboratories 14.3.13 F. Hoffman-La Roche Ltd. |
Market Breakup by Composition
- Mono Vaccines
- Combination Vaccines
Market Breakup by Disease
- Hepatitis A
- Hepatitis B
- Japanese Encephalitis Vaccines
- Meningococcal
- Rabies
- Typhoid
- Yellow Fever
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- Latin America